Publications by authors named "S Vloemans"

The pursuit of carbon circularity in the fabrication of new materials has driven the increased use of recycled and biobased resources, a practice that has become more prevalent in recent years. In epoxy resin systems, alternatives to the use of fossil-based bisphenols have been proposed such as via the production of recycled bisphenol A (r-BPA) or by substitution with lignin derivatives, both of which are recovered from previous processes, promoting circularity. For this study, r-BPA was obtained via the chemical recycling of plastic blends from end-of-life (eol) televisions (TV).

View Article and Find Full Text PDF

The curative benefits of autologous and allogeneic transplantation of hematopoietic stem cells (HSCs) have been proven in various diseases. However, the low number of true HSCs that can be collected from patients and the subsequent in vitro maintenance and expansion of true HSCs for genetic correction remains challenging. Addressing this issue, we here focused on optimizing culture conditions to improve ex vivo expansion of true HSCs for gene therapy purposes.

View Article and Find Full Text PDF

Background: The rs72824905 single-nucleotide polymorphism in the PLCG2 gene, encoding the p.P522R residue change in Phospholipase C gamma 2 (PLCγ2), associates with protection against several dementia subtypes and with increased likelihood of longevity. Cell lines and animal models indicated that p.

View Article and Find Full Text PDF

T cell development in the mouse thymus has been studied extensively, but less is known regarding T cell development in the human thymus. We used a combination of single-cell techniques and functional assays to perform deep immune profiling of human T cell development, focusing on the initial stages of prelineage commitment. We identified three thymus-seeding progenitor populations that also have counterparts in the bone marrow.

View Article and Find Full Text PDF

The ex vivo expansion and maintenance of long-term hematopoietic stem cells (LT-HSC) is crucial for stem cell-based gene therapy. A combination of stem cell factor (SCF), thrombopoietin (TPO), FLT3 ligand (FLT3) and interleukin 3 (IL3) cytokines has been commonly used in clinical settings for the expansion of CD34 from different sources, prior to transplantation. To assess the effect of IL3 on repopulating capacity of cultured CD34 cells, we employed the commonly used combination of STF, TPO and FILT3 with or without IL3.

View Article and Find Full Text PDF